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ABSTRACT
Recent clinical and experimental animal studies have 
provided evidence for a pivotal role of T lymphocytes 
and Th2 cytokines in the development of allergic in-
flammatory responses and airway hyperreactivity.
These studies suggest also that the Th2 cytokine-asso-
ciated inflammatory responses are potential targets of 
developing novel and effective therapies. Using a
novel gene-transfer approach, we investigated the role
of a Th2-inhibitory cytokine, IFN-γ, in the regulation of
antigen (Ag)-induced lung inflammatory response and
airway hyperreactivity by transfer of the IFN-γ gene
into mouse lung mucosal cells. Our results showed
that mice receMng the IFN-γ gene demonstrate a
lower degree of Ag- and Th2 cell-induced airway 
hyperresponsiveness and a reduced eosinophilia in 
the lung. These results provided evidence that the
instillation ofthe IFN-γ gene into the lung is effective in
modulating the allergic inflammation and bronchial 
hyperreactivity in an experimental animal model.
Key words: airway hyperreactivity, allergic inflamma-
tion, gene transfer, Th2 cytokines.
INTRODUCTION
Allergen-induced IgE and inflammatory responses have 
been implicated in the pathogenesis of a variety of aller-
gic diseases, including asthma.1 The inflammation is 
characterized by various types of cellular infiltrates, in-
cluding eosinophils and T cells. Numerous clinical and 
experimental animal studies have indicated a pivotal role 
of T lymphocytes and cytokines in the development of
allergic inflammatory responses and airway hyperreactiv-
ity.2-9 In particular, a subset (Th2) of CD4+ T cells, which 
has been distinguished functionally by its pattern of
cytokine secretion, is thought to play a key role. Th2 cells 
are thought to promote pulmonary allergic responses 
through their secretion of the cytokines IL-4 and IL-5,
which promote IgE production and mast cell develop-
ment, and eosinophilia, respectively.10-12 Cytokines
rel ased by the opposing pathway (Th1), such as LFN-γ,
inhibit the development and expansion of Th2 cells and 
cytokine production.10 These studies demonstrate that air-
way inflammation plays a critically important role in
mediating bronchial hyperresponsiveness. It is also evi-
dent that the Th2 cytokine-associated inflammatory 
responses are potential targets for developing novel and
effective therapeutic regimens.
 Recent advances in the genetic manipulation of 
somatic cells and tissues as a form of 'gene therapy' have 
provided an important and novel therapeutic approach
in a variety of human genetic and acquired diseases. In 
regard to the lung diseases, the use of gene therapy has 
been to modify the milieu of the tissue or directly modify
cells within the tissue, with the purpose of modulating the 
progression of disorders; for example, there have recently 
been several attempts to transfer normal cystic fibrosis
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transmembrane conductance regulator (CFTR) genes to 
airway epithelial cells in vivo.13-15 The objective of a later 
study by Li et al. was, therefore, to explore the potential
modulation of antigen-induced allergic responses by 
using gene-transfer approaches.16 In this study, we inves-
tigated the role of a Th2-inhibitory cytokine, IFN-γ, in the
regulation of Ag-induced lung inflammatory response
and airway hyperreactivity by transfer of the IFN-γ gene
into mouse lung mucosal cells.16 We hypothesized that
delivery ofthe IFN-γ gene to the mucosal cells ofthe lung
would decrease local eosinophilic inflammation, thereby 
limiting tissue destruction and loss of pulmonary function. 
To test this hypothesis, we utilized a murine model of
Ag-induced allergic inflammation and bronchial hyper-
reactivity, in which Ag exposure or challenge induced 
pulmonary eosinophilia and airway hyperreactivity, con-
comitant with increases of Th2 cytokines.8,9 Significantly,
apotent IFN-γ inducer, IL-12, has been shown to be able
to reverse the Ag-induced inflammation and airway
hyperresponsiveness in our murine model.8 We present 
here a brief description and summary of our studies (for 
detailed information and methodology, see ref. 16).
METHODS
IFN-γ gene construct and mucosal gene
transfer
To generate an IFN-γ gene construct, the IFN-γ coding-
region gene was inserted into the polylinker site of an 
expression vector, pCDNA3, containing a bovine growth 
hormone poly A tail, and a neo gene. The expression of
the IFN-γ insert is driven by a CMV promoter. The result-
ing plasmids were propagated in Escherichia coli and
purified by an additional cesium chloride gradient purifi-
cation to minimize endotoxin contamination. Table 1
describes the gene construct and route of gene transfer 
used in this study (see also ref. 16). For liposome-medi-
ated mucosal gene transfer, groups of mice were treated 
through aspiration, at varying time points, with phos-
phate-buffered saline (PBS) or IipofectAMINE, or a mix-
ture of plasmid DNA and IipofectAMINE.
Mice, immunization, cell transfer, analysis of 
airw y response and cytokines
For generating Ag- and Th2 cell-induced airway allergic 
responses, the protocols for Ag immunization, challenge, 
and Ag-specific Th2 cell transfer have been published
elsewhere.16 Various quantitative parameters of airway 
inflammation and bronchial responsiveness were also 
obtained as previously described.16 Briefly, AKR mice
were sensitized intraperitoneally tyith 100μg of conalbu-
min (CA) or PBS absorbed in 2mg of alum on PBS once 
a week for two weeks, followed by intratracheal chal-
lenge twice(1 week apart)with 100μg of CA in PBS or
PBS alone. A CA-specific T-cell clone, D10.G4.1 derived 
from AKR/J mice, was used in cell transfer experiments.
Prior to cell transfer, resting D10cells(5×106 cells in
0.05mL with or without the addition of Ag (CA, 100
μg/mL)were transferred intratracheally into naive mouse
lungs. Control mice received either Ag alone, PBS or 
remained untreated. Three days after the last Ag chal-
lenge and at various time points after cell transfer, airway
responsiveness was determined. The peak airway pres-
sure changes over time following intravenous injection of
mice with acetylcholine (Ach; 50μg/mL) were measured
as airway pressure-time index (APTI, cm H2O-s).8-9 The 
lungs were then lavaged, and the bronchoalveolar 
lavage fluid (BALE) cell differential counts and percent-
ages were determined by Diff-Quik staining of cytospin
slides. The levels of cytokines (IL-4, IL-5, IFN-γ) in the
BALF were determined by ELISA as previously described.16
RESULTS AND DISCUSSION
We first developed a murine model for studying the air-
way allergic responses16 (and Li et al., unpubl. data). In 
this model, male AKR mice (6-8 weeks old) were
intr peritoneally sensitized and intratracheally chal-
leng  with CA or PBS. Three days after the challenge, 
mic  were anesthesized and bronchoalveolar lavages
were performed. The airway reactivity was also deter-
mined by measuring airway pressure changes following 
intravenous injection of mice with Ach. The time-inte-
Table 1. Gene constructs used
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grated change in peak airway pressure, referred to as 
APTI, was calculated and served as the measurement of
airway responsiveness.8,9 We demonstrated that signifi-
cant increase in airway reactivity is observed in CA-chal-
lenged mice as compared with saline challenged mice. 
Concomitant with increases in airway reactivity, the num-
ber of eosinophils in the BALF was significantly increased
in Ag-challenged animals as compared with their con-
trols. On the other hand, Ag challenge had no significant 
effect on the numbers of either macrophages or neu-
trophils in BAL fluids of sensitized mice. In addition, 
histological examinations of the challenged lungs 
demonstrated predominant infiltrating eosinophils in the
connective tissues between blood vessels and the air-
ways; results also showed perivascular accumulation of 
the inflammatory cells including eosinophils and lympho-
cytes. Furthermore, these allergic responses can be seen 
in naive mice following adoptive transfer of naive mice 
with a CA-specific Th2 clone, D10 (Li et al, unpubl. data).
Using this murine model and the IFN-γ gene construct,
we performed a gene transfer study to examine the in vivo
efficacy of transduced IFN-γ genes on the expression of
Ag- and Th2-cell-induced inflammatory and bronchial 
responses in mice. We first analyzed the tissue expres-
sion of IFN-γ following administration of the plasmid-
liposome mixture through aspiration. The level of IFN-γ
in the BALF was determined by ELISA assays of BALF col-
lected at various time points (12, 24, 48 and 72h). Naive 
mice received either no treatment, vector control (mock;
pcDNA,10μg/mouse) or pcDNAIFN (10μg/mouse).
Results showed that while BALF from untreated or mock-
treated mice had no detectable IFN-γ, a time-dependent
increase in IFN-γ levels was observed in micetreated with
pcDNAIFN, but not with a vector control (pcDNA). In 
addition, in situ hybridization analysis showed that the
expression of IFN-γ was Iocalized predominantly in the
epithelial cells, and few pneumocytes were also stained
positive. The expression of IFN-γ transcripts and the pres-
ence of the pcDNAIFN gene construct was detected only 
in the lungs, but not in the spleens or livers, of transduced 
mice.
Using the plasmid-based construct, the in vivo efficacy
of transduced IFN-γ in modulating both CA-and Th2-
cell-induced airway allergic responses was examined.
Our results showed that mice receiving pcDNAIFN 
demonstrate a lower degree (P<0.001 vs mock-
transduced group; Statview, Brain power Inc., Calabasas,
CA, USA) of Ag-induced airway responsiveness and a 
reduced eosinophilia in the lung BALF (Fig. 1). In con-
trast, IipofectAMINE- or mock-transduced mice showed a 
similar level of airway hyperreactivity and eosinophilic
Fig. 1 (a) Male AKR mice were sensitized i. p. with conalbumin
(CA,100μg)or phosphate-buffered saline (PBS) 14days prior
to intratracheal challenges with either PBS or CA (50μg).Three
days prior to intratracheal chatllenge, mice aspirated 50μL of
the following:
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Fig. 2 Forty-eight hours prior to the Th2 (D10) cell transfer, naive mice aspirated 50μL of the following:
inflammation as that of mice challenged with Ag alone. 
Also of significance is the finding that a significant 
decrease in the levels of eosinophils and Th2 cytokines
(IL-4 and IL-5) in the BALF was observed in mice receiving
the IFN-γ gene transfer (Fig. 2; P<0.001 vs mock-trans-
duced group; Statview) 48-h prior to the cell transfer. 
These results demonstrated the feasibility of the gene-
transfer approach, and provided evidence that instilla-
tions of IFN-γ gene into the lung are effective in inhibiting
the allergic inflammation and bronchial hyperreactivity. 
Our ongoing studies involve examinations of the level,
distribution and stability of the transduced IFN-γ gene,
and of the inhibitory mechanisms of the transduced /FN-
γ genes in vivo.
 Airway inflammation and bronchial hyperreactivity are 
associated with cellular infiltrations, and are character-
ized by activation of Th2 cytokines. Our studies were 
designed to explore the potential therapeutic approach
using cytokine-gene transfer in the regulation of lung in-
flammatory response and airway hyperreactivity. Further-
more, similar gene-transfer approaches using different 
cytokine genes either individually or in combination can 
potentially be studied to gain further understanding of the
molecular mechanisms of cytokine involvement in the 
regulation of airway inflammation and bronchial hyperre-
activity. Also of interest are the recent findings that intra-
muscular allergen-gene transfer results in the expression 
of allergen in the muscle cells, and in the development of 
the immune response through a distinct antigen-presen-
tation pathway. Such an immune response is inhibitory to 
the subsequent induction of specific IgE and airway 
hyperreactivity by the allergen proteins.17,18 These molec-
ul  and functional studies provide the experimental basis 
n eded to investigate further the general applicability of 
this approach.
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